コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d accuracy using manual tumor annotations by pathologist.
2 e histology was confirmed by a genitourinary pathologist.
3 s that shaped my career as a molecular plant pathologist.
4 d histopathology findings from the reference pathologist.
5 d scoring showed a concordance of 83% with a pathologist.
6 allocation in consensus with a second expert pathologist.
7 type-specific markers and subclassified by a pathologist.
8 g histological analysis by an expert cardiac pathologist.
9 creatic transection line frozen samples by a pathologist.
10 thologist and, when appropriate, a molecular pathologist.
11 length against measurements by the reporting pathologist.
12 n of hematoxylin & eosin stained tissue by a pathologist.
13 he assessment of a kidney biopsy sample by a pathologist.
14 es the expertise of an experienced perinatal pathologist.
15 rd color bright-field image, familiar to the pathologist.
16 quires annotation of the tumour regions by a pathologist.
17 g nephrologists, oncologists, urologists and pathologists.
18 The results may vary among pathologists.
19 erver and inter-observer variability amongst pathologists.
20 issue blocks were examined by expert cardiac pathologists.
21 thologists were higher than those made by US pathologists.
22 robserver agreement was determined between 3 pathologists.
23 s are concordant and reproducible as read by pathologists.
24 were analyzed by local and blinded reference pathologists.
25 amples of BE tissues between US and European pathologists.
26 s), as assessed centrally by two independent pathologists.
27 uld help save time and cost for surgeons and pathologists.
28 interpreted by a reference group of 3 expert pathologists.
29 sues per participant, were reviewed by study pathologists.
30 misclassified as high risk by institutional pathologists.
31 the surface that are readily interpreted by pathologists.
32 nd its interpretation remains a challenge to pathologists.
33 sections were independently scored by three pathologists.
34 t appears histologically normal according to pathologists.
35 ing to Metavir classification by two blinded pathologists.
36 patologists and one of two experienced liver pathologists.
37 were reviewed independently by two pulmonary pathologists.
38 lls in tissue microarrays were scored by two pathologists.
39 can decrease interobserver variations among pathologists.
40 fer markedly between entomologists and plant pathologists.
41 ter than manually annotated stages by cancer pathologists.
42 which empowers mass cytometers to 'see' like pathologists.
43 ications and are often based upon scoring by pathologists.
44 e was systematically assessed by two blinded pathologists.
45 hological diagnoses were made by experienced pathologists.
46 ually labeled by experienced speech language pathologists.
47 regions of the world lack access to trained pathologists.
48 biopsy samples were then analysed by masked pathologists.
49 e and knowledge sharing between site and CPL pathologists.
51 sia) were identified, randomly assigned to 7 pathologists (4 from the United States and 3 from Europe
52 ng 528 patients with high-risk GIST by local pathologist, 5-year IFFS was 79% versus 73%; among 336 c
53 an Association of Ophthalmic Oncologists and Pathologists (AAOOP) with support of the American Associ
54 The biopsies were scored by 2 blinded expert pathologists according to nonalcoholic steatohepatitis c
55 hed tools available in a College of American Pathologists-accredited and Clinical Laboratory Improvem
57 of Medical Genetics and American College of Pathologists (ACMG/AMP) variant classification guideline
59 for progression increased greatly when all 3 pathologists agreed on LGD (odds ratio, 47.14; 95% confi
62 slides were reviewed by a single pancreatic pathologist and classified on the basis of epithelial ty
63 or sample and subjecting it to analysis by a pathologist and, when appropriate, a molecular pathologi
65 ould decrease interobserver variations among pathologists and are likely to be implemented in patholo
67 e been written aimed at offering a guide for pathologists and clinicians in diagnosing and treating P
69 highlight the synergistic possibilities for pathologists and DNNs to radically scale up our ability
70 r open reading of both sample types by local pathologists and final diagnosis at a second MDA (MDA2),
71 disease of abnormally aggregated proteins by pathologists and molecular biologists and a disease of c
74 wed high interobserver reproducibility among pathologists and was validated in a second PTCL-NOS coho
76 he collaboration of the clinician, the renal pathologist, and the biochemical and genetic laboratory
79 luded representative ophthalmic oncologists, pathologists, and geneticists from retinoblastoma referr
81 ts, physical therapists, speech and language pathologists, and others can positively affect patient c
82 l cases were reviewed by GI gastrointestinal pathologists, and pathologic features were analyzed to i
84 s on 170 breast and colon cancer images with pathologist-annotated nuclei, finding that both cellular
89 mitted to Associated Regional and University Pathologists (ARUP) Laboratories and tested by clinicall
91 Purpose ASCO and the College of American Pathologists (ASCO-CAP) recently recommended further cha
94 he participants' (95 clinicians and 72 renal pathologists) assigned diagnoses were compared to the Ba
97 al implementation of these approaches, guide pathologists at the CPL and CHAMPS sites through standar
98 for transplantation were analyzed by expert pathologists, ATR-FTIR spectroscopy, lipid biochemical a
99 ely to have favorable opinions of safety and pathologist availability, and more influenced by safety,
100 d diagnosis of SRH images was noninferior to pathologist-based interpretation of conventional histolo
101 disciplinary group of pediatric oncologists, pathologists, biologists, and radiologists convened duri
103 was diagnosed by an expert gastrointestinal pathologist blinded to the colonoscope allocation in con
104 The biopsy specimens were analyzed by a pathologist blinded to the results of VCTE for the stage
112 tration according to the College of American Pathologists (CAP) and Royal College of Pathologists (RC
115 of 1988 (CLIA '88), the College of American Pathologists (CAP), and the Joint Commission on Accredit
116 inical Pathology (ASCP), College of American Pathologists (CAP), Association for Molecular Pathology
119 ling tasks (83% and 87%), as compared to the pathologist concordance achieved by the automated method
120 cal Association, and the College of American Pathologists, conducted a systematic literature review o
124 tween outcomes and factors such as number of pathologists confirming LGD, multifocality of LGD, and p
125 infectious disease specimen volume to have a pathologist dedicated full time to this crosscutting sub
126 d be confirmed by an expert gastrointestinal pathologist (defined as a pathologist with a special int
128 niches suitable for evaluation by diagnostic pathologists, describes neoplastic lesions associated wi
129 tool to increase efficiency and accuracy of pathologists detecting head and neck cancers in histolog
135 ted by independent measures of tumor purity, pathologists' estimate of lymphocyte density, imputed im
136 nostic workup of lung adenocarcinomas (LAC), pathologists evaluate distinct histological tumor growth
137 ment in level of agreement among experienced pathologists, even after accounting for inflammation.
138 ur protocols are written for researchers and pathologists experienced in conventional fluorescence mi
139 ep learning have the potential to supplement pathologist expertise to ensure constant diagnostic accu
140 s born, the examination of the placenta by a pathologist for abnormalities, such as infection or mate
142 f 0.525 and an agreement of 66.6% with three pathologists for classifying the predominant patterns, s
143 rdance (240/254) between local and consensus pathologists for hHSIL vs less than hHSIL (kappa = 0.86
148 er-observer agreement among gastrointestinal pathologists from 5 tertiary centers in the United State
149 ng clinical management, ERS is determined by pathologists from immunohistochemistry (IHC) staining of
150 vidually graded by 23 experienced urological pathologists from the International Society of Urologica
151 125) for LGD, confirmed by at least 1 expert pathologist, from October 1992 through December 2013 at
152 of at least one clinician, radiologist, and pathologist, from seven countries (Denmark, France, Ital
157 everity of disease across treatment cohorts, pathologists have historically assigned a semi-quantitat
161 instances of fibrosis, as identified by the pathologist, highlights the advantage of the DFIR imagin
166 n is required by the gastroenterologists and pathologists in diagnosing these cases as these tumors c
167 d in clinical practice, our model can assist pathologists in improving classification of lung adenoca
169 uating adequacy of LN yield for surgeons and pathologists in the treatment of papillary thyroid cance
170 stologic findings, read by experienced renal pathologists, in 975 postreperfusion biopsy specimens co
171 greement, even among expert gastrointestinal pathologists, in the diagnosis of low-grade dysplasia (L
172 greement, even among expert gastrointestinal pathologists, in the diagnosis of low-grade dysplasia (L
174 cally complete resection (according to local pathologists), included in the central pathology review,
177 scores obtained greater concordance with the pathologist interpretations for both image-labeling and
178 de, overall agreement between the individual pathologists' interpretations and the expert consensus-d
180 of presence and extent of breast cancer by a pathologist is critical for patient management for tumor
184 ant patterns, slightly higher than the inter-pathologist kappa score of 0.485 and agreement of 62.7%
185 erver agreement was substantial among the US pathologists (kappa, 0.63; 95% CI, 0.61-0.66) and Europe
194 nd critical care intensivists, radiologists, pathologists, organ procurement personnel, and research
197 egarding reproducibility between studies and pathologists, potentially masking successful treatments.
201 psies and a worldwide shortage of urological pathologists puts a strain on pathology departments.
202 with mesangial matrix expansion scored by a pathologist (R.E.C.), which differed in these animals.
203 COPD overlap was discussed among clinicians, pathologists, radiologists, epidemiologists, and investi
205 ican Pathologists (CAP) and Royal College of Pathologists (RCP) on long-term survival of 180 patients
208 ety of Clinical Oncology/College of American Pathologists recommendations for HER2 testing in breast
209 ety of Clinical Oncology/College of American Pathologists recommendations for human epidermal growth
210 ut prostate core biopsies by two independent pathologists resulted in an area under the receiver oper
215 rm a revision, we suggest leaving it to each pathologist's discretion whether to use i0 or i1 as the
216 ostic techniques extend the frontiers of the pathologist's view beyond a microscopic slide and enable
219 high accuracy of our system based on expert pathologists' scores (cancer = 97.1%, stromal = 89.1%) a
221 or any single assay, the concordance between pathologists' scoring for PD-L1 expression in tumor cell
224 Two clinicians, two radiologists, and two pathologists sequentially reviewed clinical-radiologic f
226 in clinical practice, and consider ways the pathologist should be involved in interpreting liquid bi
234 a committee of radiologists, hepatologists, pathologists, surgeons, lexicon experts, and ACR staff,
236 significant interobserver variability among pathologists, the diagnosis of Barrett's esophagus with
239 ubjective and difficult to reproduce between pathologists, tissue morphology often takes a back seat
243 ption for H. pylori that can potentially aid pathologists to accurately diagnose H. pylori presence o
244 ere "software-assisted sign-out" will enable pathologists to conduct objective analyses that can be i
247 operative communication between surgeons and pathologists to ensure appropriate and timely treatment
249 ers with assistance and guidance from speech pathologists to help improve HNC complications and QOL f
250 lso known as NKX2-1), is used as a marker by pathologists to identify lung adenocarcinomas since TTF-
251 suggest that QPI shows promise in assisting pathologists to improve prediction of prostate cancer re
252 per storage solutions has made it easier for pathologists to manage digital slide images and share th
253 ticipants, ranging in experience from senior pathologists to medical students, to delineate tissue re
255 nucleus, as shape and size, have served for pathologists to stratify and diagnose cancer patients; h
256 his comprehensive review attracts more plant pathologists to the study of this key plant defense resp
262 compared with DS slide assessments by three pathologists using a microscope and a fourth pathologist
263 slides were scored by three expert pulmonary pathologists using a standardized nomenclature and scori
267 ed in resection specimens by two independent pathologists using the Mandard tumor regression grading
270 pathologists using a microscope and a fourth pathologist via manually ticking off each cell, the latt
271 cted by the AI and assigned by the reporting pathologist was 0.96 (95% CI 0.95-0.97) for the independ
272 diagnostic interpretations of participating pathologists was 75.3% (95% CI, 73.4%-77.0%; 5194 of 690
274 s survey and through a congress of concerned pathologists, we propose strategies that will catapult t
276 Sixty-five percent of invited, responding pathologists were eligible and consented to participate.
277 pa values for all diagnoses made by European pathologists were higher than those made by US pathologi
279 nvestigators, clinical trial site staff, and pathologists were masked to treatment assignment through
281 aluation metrics for our model and the three pathologists were within 95% confidence intervals of agr
282 ples, roughly double the accuracy of trained pathologists when presented with a metastatic tumour wit
283 nfectious disease clinicians tend to consult pathologists when there are questions regarding terminol
284 on mechanism on tumoral areas annotated by a pathologist whereas the second ("CHOWDER") does not requ
285 The slides were scanned and scored by 13 pathologists who estimated the percentage of malignant a
287 CI, 75%-80%] for lower, P < .001), and among pathologists who interpreted lower weekly case volumes (
289 lanoma (MEL) scale of 0 to 5 by one of three pathologists who were blinded to clinical outcome; a sco
290 digital classification agreed with a senior pathologist whose classifications were used as ground tr
292 ng cases and their clinical information with pathologists will help to conduct consistent and reliabl
293 intracellular signaling pathways, diagnostic pathologists will play an increasingly important part in
294 t gastrointestinal pathologist (defined as a pathologist with a special interest in Barrett's esophag
295 in a blinded fashion by an expert veterinary pathologist with attention paid to the applicability of
297 ssment of G4 proportion uses estimation by a pathologist, with a higher proportion of G4 more likely
298 infrastructures, modification of laboratory/pathologist workflows, appropriate reimbursement/cost-of
300 group electronically surveyed clinicians and pathologists worldwide regarding diagnosis and treatment